Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosci Biobehav Rev ; 142: 104867, 2022 11.
Article in English | MEDLINE | ID: mdl-36122739

ABSTRACT

Mental health disorders and substance use disorders are a leading cause of morbidity and mortality worldwide, and one of the most important challenges for public health systems. While evidence-based psychotherapy is generally pursued to address mental health challenges, psychological change is often hampered by non-adherence to treatments, relapses, and practical barriers (e.g., time, cost). In recent decades, Non-invasive brain stimulation (NIBS) techniques have emerged as promising tools to directly target dysfunctional neural circuitry and promote long-lasting plastic changes. While the therapeutic efficacy of NIBS protocols for mental illnesses has been established, neuromodulatory interventions might also be employed to support the processes activated by psychotherapy. Indeed, combining psychotherapy with NIBS might help tailor the treatment to the patient's unique characteristics and therapeutic goal, and would allow more direct control of the neuronal changes induced by therapy. Herein, we overview emerging evidence on the use of NIBS to enhance the psychotherapeutic effect, while highlighting the next steps in advancing clinical and research methods toward personalized intervention approaches.


Subject(s)
Substance-Related Disorders , Transcranial Direct Current Stimulation , Humans , Transcranial Magnetic Stimulation/methods , Transcranial Direct Current Stimulation/methods , Psychotherapy/methods , Substance-Related Disorders/therapy , Brain/physiology
2.
J Alzheimers Dis ; 85(4): 1667-1676, 2022.
Article in English | MEDLINE | ID: mdl-34958021

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is characterized by diffuse amyloid-ß (Aß) and phosphorylated Tau (p-Tau) aggregates as well as neuroinflammation. Exogenously-induced 40 Hz gamma oscillations have been showing to reduce Aß and p-Tau deposition presumably via microglia activation in AD mouse models. OBJECTIVE: We aimed to translate preclinical data on gamma-induction in AD patients by means of transcranial alternating current stimulation (tACS). METHODS: Four participants with mild-to-moderate AD received 1 h of daily 40 Hz (gamma) tACS for 4 weeks (Monday to Friday) targeting the bitemporal lobes (20 h treatment duration). Participant underwent Aß, p-Tau, and microglia PET imaging with [11C]-PiB, [18F]-FTP, and [11C]-PBR28 respectively, before and after the intervention along with electrophysiological assessment. RESULTS: No adverse events were reported, and an increase in gamma spectral power on EEG was observed after the treatment. [18F]-FTP PET revealed a significant decrease over 2% of p-Tau burden in 3/4 patients following the tACS treatment, primarily involving the temporal lobe regions targeted by tACS and especially mesial regions (e.g., entorhinal cortex). The amount of intracerebral Aß as measured by [11C]-PiB was not significantly influenced by tACS, whereas 1/4 reported a significant decrease of microglia activation as measured by [11C]-PBR28. CONCLUSION: tACS seems to represent a safe and feasible option for gamma induction in AD patients, with preliminary evidence of a possible effect on protein clearance partially mimicking what is observed in animal models. Longer interventions and placebo control conditions are needed to fully evaluate the potential for tACS to slow disease progression.


Subject(s)
Alzheimer Disease , Transcranial Direct Current Stimulation , tau Proteins/metabolism , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/therapy , Amyloid beta-Peptides/metabolism , Animals , Brain/metabolism , Entorhinal Cortex/metabolism , Female , Humans , Male , Mice , Microglia/metabolism , Positron-Emission Tomography , Temporal Lobe/metabolism
3.
Alzheimers Res Ther ; 13(1): 203, 2021 12 20.
Article in English | MEDLINE | ID: mdl-34930421

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is associated with alterations in cortical perfusion that correlate with cognitive impairment. Recently, neural activity in the gamma band has been identified as a driver of arteriolar vasomotion while, on the other hand, gamma activity induction on preclinical models of AD has been shown to promote protein clearance and cognitive protection. METHODS: In two open-label studies, we assessed the possibility to modulate cerebral perfusion in 15 mild to moderate AD participants via 40Hz (gamma) transcranial alternating current stimulation (tACS) administered 1 h daily for 2 or 4 weeks, primarily targeting the temporal lobe. Perfusion-sensitive MRI scans were acquired at baseline and right after the intervention, along with electrophysiological recording and cognitive assessments. RESULTS: No serious adverse effects were reported by any of the participants. Arterial spin labeling MRI revealed a significant increase in blood perfusion in the bilateral temporal lobes after the tACS treatment. Moreover, perfusion changes displayed a positive correlation with changes in episodic memory and spectral power changes in the gamma band. CONCLUSIONS: Results suggest 40Hz tACS should be further investigated in larger placebo-controlled trials as a safe, non-invasive countermeasure to increase fast brain oscillatory activity and increase perfusion in critical brain areas in AD patients. TRIAL REGISTRATION: Studies were registered separately on ClinicalTrials.gov ( NCT03290326 , registered on September 21, 2017; NCT03412604 , registered on January 26, 2018).


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Transcranial Direct Current Stimulation , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/therapy , Hippocampus , Humans , Perfusion , Transcranial Direct Current Stimulation/methods
4.
Ageing Res Rev ; 61: 101067, 2020 08.
Article in English | MEDLINE | ID: mdl-32380212

ABSTRACT

As we age, sleep patterns undergo severe modifications of their micro and macrostructure, with an overall lighter and more fragmented sleep structure. In general, interventions targeting sleep represent an excellent opportunity not only to maintain life quality in the healthy aging population, but also to enhance cognitive performance and, when pathology arises, to potentially prevent/slow down conversion from e.g. Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD). Sleep abnormalities are, in fact, one of the earliest recognizable biomarkers of dementia, being also partially responsible for a cascade of cortical events that worsen dementia pathophysiology, including impaired clearance systems leading to build-up of extracellular amyloid-ß (Aß) peptide and intracellular hyperphosphorylated tau proteins. In this context, Noninvasive Brain Stimulation (NiBS) techniques, such as transcranial electrical stimulation (tES) and transcranial magnetic stimulation (TMS), may help investigate the neural substrates of sleep, identify sleep-related pathology biomarkers, and ultimately help patients and healthy elderly individuals to restore sleep quality and cognitive performance. However, brain stimulation applications during sleep have so far not been fully investigated in healthy elderly cohorts, nor tested in AD patients or other related dementias. The manuscript discusses the role of sleep in normal and pathological aging, reviewing available evidence of NiBS applications during both wakefulness and sleep in healthy elderly individuals as well as in MCI/AD patients. Rationale and details for potential future brain stimulation studies targeting sleep alterations in the aging brain are discussed, including enhancement of cognitive performance, overall quality of life as well as protein clearance.


Subject(s)
Alzheimer Disease , Brain/physiology , Cognitive Dysfunction , Deep Brain Stimulation , Transcranial Magnetic Stimulation , Aged , Aging , Alzheimer Disease/therapy , Amyloid beta-Peptides , Brain/pathology , Cognitive Dysfunction/therapy , Humans , Quality of Life , Sleep , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/therapy
5.
J Couns Psychol ; 66(5): 600-612, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30998050

ABSTRACT

Globalization, technological advancements, and macroeconomic forces have created significant challenges for working in the United States and other countries. Recent crises about working include long-term unemployment/underemployment and the rise of precarious work, which negatively impact individuals' mental health and well-being. To fully understand the nature and impact of these problems, it is essential to give voice to the people whose lives are affected by the work-related crises. In the present study, we used social constructionism and the Psychology of Working Framework/Theory to understand how 42 American adults from diverse backgrounds make meaning of the crises about work. We used modified consensual qualitative research to analyze the participants' responses to a question on their potential solutions to the crises about work in the United States. The data analysis revealed 3 domains: government and corporate policies, social justice, and values. These domains were interwoven with each other through the threads of emotional reactions, locus of causality, and political ideology. Implications for vocational psychology theory, research, policy, and practice are discussed. (PsycINFO Database Record (c) 2019 APA, all rights reserved).


Subject(s)
Culture , Employment/psychology , Job Satisfaction , Qualitative Research , Social Justice/psychology , Unemployment/psychology , Adult , Aged , Female , Health Status , Humans , Male , Mental Health , Middle Aged , United States/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL